The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.

The Gram-negative enteric bacterium Proteus mirabilis is a frequent cause of urinary tract infections (UTIs) in individuals with long-term indwelling catheters or with complicated urinary tracts. The recent release of the P. mirabilis strain HI4320 genome sequence has facilitated identification of potential virulence factors in this organism. Genes appearing to encode a type III secretion system (TTSS) were found in a low GC-content pathogenicity island in the P. mirabilis chromosome. This island contains 24 intact genes that appear to encode all components necessary to assemble a TTSS needle complex, plus at least two putative secreted effector proteins and their chaperones. The genetic organization of the TTSS genes is very similar to that of the TTSS of Shigella flexneri. RT-PCR analysis indicated that these genes are expressed at low levels in vitro. However, insertional mutation of two putative TTSS genes, encoding the requisite ATPase and a possible negative regulator, resulted in no change in either the growth rate of the mutant or the secreted protein profile compared to wild-type. Furthermore, there was no difference in quantitative cultures of urine, bladder and kidney between the ATPase mutant and the wild-type strain in the mouse model of ascending UTI in either independent challenge or co-challenge experiments. The role of the P. mirabilis TTSS, if any, is yet to be determined.

[1]  G. Cornelis,et al.  The type III secretion injectisome , 2006, Nature Reviews Microbiology.

[2]  G. Cornelis,et al.  The bacterial injection kit: Type III secretion systems , 2005, Annals of medicine.

[3]  C. Constantinidou,et al.  Regulators Encoded in the Escherichia coli Type III Secretion System 2 Gene Cluster Influence Expression of Genes within the Locus for Enterocyte Effacement in Enterohemorrhagic E. coli O157:H7 , 2004, Infection and Immunity.

[4]  J. Alfano,et al.  Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity , 2004, Cellular microbiology.

[5]  A. Collmer,et al.  EFFECTOR PROTEINS : Double Agents in Bacterial Disease and Plant Defense , 2004 .

[6]  Mark J. Pallen,et al.  The ETT2 Gene Cluster, Encoding a Second Type III Secretion System from Escherichia coli, Is Present in the Majority of Strains but Has Undergone Widespread Mutational Attrition , 2004, Journal of bacteriology.

[7]  T. Pawson,et al.  Identification and characterization of NleA, a non‐LEE‐encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7 , 2004, Molecular microbiology.

[8]  Pradeep K. Singh,et al.  ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon , 2002, Molecular microbiology.

[9]  N. W. Davis,et al.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7 , 2001, Nature.

[10]  M. Hattori,et al.  Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. , 2001, DNA research : an international journal for rapid publication of reports on genes and genomes.

[11]  C. Buchrieser,et al.  The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri , 2000, Molecular microbiology.

[12]  H. Mobley,et al.  Pathogenesis of Proteus mirabilis urinary tract infection. , 2000, Microbes and infection.

[13]  H. Mobley,et al.  Requirement of MrpH for Mannose-ResistantProteus-Like Fimbria-Mediated Hemagglutination byProteus mirabilis , 1999, Infection and Immunity.

[14]  R. Belas,et al.  ZapA, the IgA‐degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells , 1999, Molecular microbiology.

[15]  Jeff F. Miller,et al.  The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica , 1998, Molecular microbiology.

[16]  P. Sansonetti,et al.  Induction of type III secretion in Shigella flexneri is associated with differential control of transcription of genes encoding secreted proteins , 1998, The EMBO journal.

[17]  B. Finlay,et al.  Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Sansonetti,et al.  Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation , 1997, Infection and immunity.

[19]  T. McDaniel,et al.  A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K‐12 , 1997, Molecular microbiology.

[20]  R. Belas,et al.  Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection , 1996, Infection and immunity.

[21]  G. Cornelis,et al.  Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica , 1996, Infection and immunity.

[22]  T. McDaniel,et al.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Frank,et al.  Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon , 1995, Journal of bacteriology.

[24]  R. Belas,et al.  Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.

[25]  R. Hull,et al.  Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes , 1995, Infection and immunity.

[26]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[27]  D. Beauchemin,et al.  Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi , 1994, Infection and immunity.

[28]  H. Mobley,et al.  Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria , 1994, Infection and immunity.

[29]  R. Ménard,et al.  Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells , 1993, Journal of bacteriology.

[30]  H. Mobley,et al.  Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains , 1993, Infection and immunity.

[31]  R. Belas,et al.  Transposon mutagenesis in Proteus mirabilis , 1991, Journal of bacteriology.

[32]  H. Mobley,et al.  Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells , 1991, Infection and immunity.

[33]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[34]  R. Welch,et al.  Cytotoxic activity of the Proteus hemolysin HpmA , 1990, Infection and immunity.

[35]  H. Mobley,et al.  Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. , 1990, The Journal of infectious diseases.

[36]  H. Wolf‐Watz,et al.  Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein , 1988, Infection and immunity.

[37]  H. Mobley,et al.  Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. , 1987, The Journal of urology.

[38]  M. Kerr,et al.  Proteus mirabilis strains of diverse type have IgA protease activity. , 1987, Journal of medical microbiology.

[39]  R. Cook,et al.  Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis , 1986, Infection and Immunity.

[40]  F. Studier,et al.  Cloning and expression of the gene for bacteriophage T7 RNA polymerase. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[42]  R. Adegbola,et al.  The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. , 1983, Journal of medical microbiology.

[43]  B. Senior.  Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation. , 1983, Journal of medical microbiology.

[44]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[45]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.